-
My Account
In App
My Account
Not Rated
|
Fund Size
(0% of Investment in Category)
|
Expense Ratio
(0.28% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 18-Nov-25 | 9983.10 | -0.17% | - | -0.47% | 182/352 |
| 1 Month | 24-Oct-25 | 9956.70 | -0.43% | - | 0.11% | 272/349 |
| 3 Month | 25-Aug-25 | 10022.70 | 0.23% | - | 2.50% | 307/342 |
| Since Inception | 20-Jun-25 | 10504.20 | 5.04% | 12.03% | 9.69% | 268/343 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| No Data Found | |||||
Please check with your Tax Advisor.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 25.2 | 18.15% | 0.48% | 18.51% (Jul 2025) | 0% (Nov 2024) | 14.89 k | 557.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 12.1 | 8.72% | 1.12% | 8.73% (Jun 2025) | 0% (Nov 2024) | 1.79 k | 67.00 |
| Max Healthcare Institute Ltd. | Hospital | 12.1 | 8.69% | -0.02% | 9.58% (Jun 2025) | 0% (Nov 2024) | 10.50 k | 392.00 |
| Cipla Ltd. | Pharmaceuticals | 11.9 | 8.60% | -0.29% | 9.32% (Aug 2025) | 0% (Nov 2024) | 7.95 k | 298.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 11 | 7.90% | 0.03% | 8.02% (Aug 2025) | 0% (Nov 2024) | 1.43 k | 53.00 |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 10.3 | 7.43% | -0.41% | 8% (Aug 2025) | 0% (Nov 2024) | 8.61 k | 322.00 |
| Fortis Healthcare Ltd. | Hospital | 7.5 | 5.43% | 0.12% | 5.43% (Oct 2025) | 0% (Nov 2024) | 7.36 k | 276.00 |
| Lupin Ltd. | Pharmaceuticals | 6.7 | 4.84% | -0.02% | 4.86% (Sep 2025) | 0% (Nov 2024) | 3.42 k | 128.00 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 5.3 | 3.79% | -0.17% | 3.96% (Sep 2025) | 0% (Nov 2024) | 1.48 k | 55.00 |
| Laurus Labs Ltd. | Pharmaceuticals | 5.2 | 3.77% | 0.33% | 3.77% (Oct 2025) | 0% (Nov 2024) | 5.49 k | 205.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.83% |
| Net Receivables | Net Receivables | -0.81% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
Out of 63 mutual fund schemes offered by this AMC, 6 is/are ranked 5 * , 8 is/are ranked 4 * , 11 is/are ranked 3 * , and 38 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| DSP Midcap Fund - Direct Plan - Growth | 3 | 19609.01 | 0.37 | 0.74 | 5.78 | 5.26 | 20.77 |
| DSP Liquidity Fund - Direct Plan - Growth | 3 | 19054.79 | 0.50 | 1.47 | 3.01 | 6.73 | 7.08 |
| DSP ELSS Tax Saver Fund - Direct Plan - Growth | 5 | 17241.31 | 1.07 | 4.08 | 3.95 | 7.27 | 20.12 |
| DSP Small Cap Fund - Direct Plan - Growth | 3 | 16867.93 | 0.45 | -0.82 | 4.34 | 3.44 | 20.96 |
| DSP Large & Mid Cap Fund - Direct Plan - Growth | 4 | 16530.07 | 0.94 | 3.52 | 4.04 | 6.87 | 20.81 |
| DSP Flexi Cap Fund - Direct Plan - Growth | 3 | 12197.68 | -0.41 | 2.49 | 2.94 | 4.93 | 18.12 |
| DSP Aggressive Hybrid Fund - Direct Plan - Growth | 4 | 11909.72 | -0.47 | 1.66 | 1.65 | 7.14 | 16.81 |
| DSP Savings Fund - Direct Plan - Growth | 4 | 7524.16 | 0.53 | 1.57 | 3.31 | 7.38 | 7.49 |
| DSP Large Cap Fund - Direct Plan - Growth | 5 | 6933.59 | -0.03 | 3.21 | 2.98 | 7.58 | 18.28 |
| DSP Arbitrage fund - Direct Plan - Growth | 3 | 6447.92 | 0.51 | 1.51 | 3.19 | 6.84 | 7.68 |
